The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations and that it's expected to produce billions in savings for older adults. But the net prices unveiled Tuesday aren't what Medicare recipients will pay at their pharmacy counters because those final amounts will depend on each individual's plan and how much they spend annually on prescriptions. Health Secretary Robert F. Kennedy Jr. touted the deals as part of efforts to address affordability concerns. The negotiation program is mandated by law and began under the Biden administration.

A coalition of nursing and other health care organizations are pushing back against a Trump administration plan that could limit access to student loans in some cases. Students pursuing graduate degrees in nursing, physical therapy and some other fields would face tighter federal student loan limits under the plan because it doesn't consider them professional programs. The revamp is part of an overhaul passed by Congress in Trump's "Big Beautiful Bill." Under current rules, graduate students can borrow loans up to the cost of their degree. But the new rules would set caps depending on whether the degree is considered a graduate or professional program. The Trump administration believes the changes could reduce tuition costs.

Higher prices, less help and a government shutdown hang over health insurance markets as shoppers start looking for coverage this week. The annual enrollment window for millions of people to pick an individual plan opens Saturday. The federal government shut down this month as Democrats in Congress demanded negotiations to extend enhanced tax credits that have helped people buy coverage the past few years. Republicans say they won't negotiate until Democrats vote to reopen the government. Stuck in the middle are insurance shoppers, many of whom will be facing the biggest premium hikes they've seen in years.

A new poll finds most U.S. adults are worried about health care becoming more expensive. That comes as Americans make decisions about next year's health coverage and a government shutdown keeps future health costs in limbo for millions. The AP-NORC poll shows about 6 in 10 Americans are "extremely" or "very" concerned about their health costs going up in the next year, a worry that extends across age groups and includes people with and without health insurance. The findings show that many Americans are feeling vulnerable to spiking health care costs, with some expressing concerns about whether they'll have coverage at all.

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump's administration. Trump made the announcement Tuesday with Pfizer CEO Albert Bourla at the White House. Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee the same pricing on newly launched drugs. That involves matching the lowest price offered in other developed nations. The agreement by Pfizfer builds on an executive order Trump signed in May setting a deadline for drugmakers to electively lower prices or face new limits on what the government will pay.